When compared to DPP-4 inhibitors, this drug class reduced the risk by four for every 1,000 PY. Our research suggested that GLP-1 agonists were associated with a lower risk of dementia compared to ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

The pharmacokinetic mechanism involves drug–drug interactions, while the pharmacodynamic mechanism comprises the possibility of enhanced pancreatic β-cell stimulation and subsequent increased ...

The results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or ...

By Dr. Priyom Bose, Ph.D. Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric conditions alongside increased risks of gastrointestinal and ...

Moreover, the employment of propensity score matching substantially reduced selection bias and the possibility of confounding by indication that is always a concern in retrospective drug studies.